Tech Company Financing Transactions
BioScale Funding Round
On 2/22/2013, BioScale raised $3.8 million in funding from private investors.
Transaction Overview
Company Name
Announced On
2/22/2013
Transaction Type
Debt
Amount
$3,827,004
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Amount includes the issuance of warrants to purchase preferred stock. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Fortune Dr.
Lexington, MA 01821
USA
Lexington, MA 01821
USA
Phone
Website
Email Address
Overview
Bioscale develops a protein measurement technology that accelerates the discovery and development of biological and pharmaceutical products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Martin Latterich
Chief Technical Officer
Brett Masters
Co-Founder
Mark Lundstrom
VP - Product Management
Michael Miller
Browse more venture capital transactions:
Prev: 2/22/2013: Medikly venture capital transaction
Next: 2/22/2013: Aggregate Knowledge venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs